(Q44512988)

3 December 2017

Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859. (English)

1 reference

3 December 2017

Yuhong Qiu

1

1 reference

3 December 2017

Sheela Bhattacharjee

2

1 reference

3 December 2017

Patricia Kraft

3

1 reference

3 December 2017

T Mathew John

4

1 reference

3 December 2017

Elizabeth Craig

5

1 reference

3 December 2017

Donna Haynes-Johnson

6

1 reference

3 December 2017

Jihua Guan

7

1 reference

3 December 2017

Weiqin Jiang

8

1 reference

3 December 2017

Mark Macielag

9

1 reference

3 December 2017

Zhihua Sui

10

1 reference

3 December 2017

Joanna Clancy

11

1 reference

3 December 2017

Scott Lundeen

12

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

European Journal of Pharmacology

3 December 2017

1 reference

3 December 2017

472

1 reference

3 December 2017

1-2

1 reference

3 December 2017

73-80

1 reference

Nitric oxide: a physiologic mediator of penile erection

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Characterization of a novel potent and specific inhibitor of type V phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

The role of phosphodiesterase inhibitors in impotence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Cyclic nucleotide phosphodiesterases: relating structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

FR226807: a potent and selective phosphodiesterase type 5 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Expression of different phosphodiesterase genes in human cavernous smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Pyrimidinylpyrroloquinolones as highly potent and selective PDE5 inhibitors for treatment of erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

A canine model for hemodynamic study of isolated corpus cavernosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901868-5

10.1016/S0014-2999(03)01868-5

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference